• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXHL1301289 波舒替尼片 bosutinib monohydrate Tablet Chemical Drugs(3.1) New Drug Application 2014-01-10 山东创新药物研发有限公司 Shandong Innovative Drug Research and Development Co Ltd Certificate Issued 2016-01-28 view
CXHL1301288 波舒替尼片 bosutinib monohydrate Tablet Chemical Drugs(3.1) New Drug Application 2014-01-10 山东创新药物研发有限公司 Shandong Innovative Drug Research and Development Co Ltd Certificate Issued 2016-01-28 view
CXHL1301287 波舒替尼 bosutinib monohydrate Active ingredient Chemical Drugs(3.1) New Drug Application 2014-01-10 山东创新药物研发有限公司 Shandong Innovative Drug Research and Development Co Ltd Certificate Issued 2016-01-28 view
CXHL1500379 波舒替尼片 bosutinib monohydrate Tablet Chemical Drugs(3.1) New Drug Application 2015-04-09 济南百诺医药科技开发有限公司 Shandong Bestcomm Pharmaceutical Company Limited Certificate Issued 2016-06-20 view
CXHL1500378 波舒替尼片 bosutinib monohydrate Tablet Chemical Drugs(3.1) New Drug Application 2015-04-09 济南百诺医药科技开发有限公司 Shandong Bestcomm Pharmaceutical Company Limited Certificate Issued 2016-06-20 view
CXHL1500377 波舒替尼 bosutinib monohydrate Active ingredient Chemical Drugs(3.1) New Drug Application 2015-04-09 济南百诺医药科技开发有限公司 Shandong Bestcomm Pharmaceutical Company Limited Certificate Issued 2016-06-20 view